Patent details

EP3463349 Title: USE OF SIROLIMUS TO TREAT EXUDATIVE AGE-RELATED MACULAR DEGENERATION WITH PERSISTENT EDEMA

Basic Information

Publication number:
EP3463349
PCT Application Number:
JP2017019551
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP178028841
PCT Publication Number:
WO2017204298
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
USE OF SIROLIMUS TO TREAT EXUDATIVE AGE-RELATED MACULAR DEGENERATION WITH PERSISTENT EDEMA
French Title of Invention:
UTILISATION DU SIROLIMUS POUR TRAITER LA DÉGÉNÉRESCENCE LIÉE À L'ÂGE EXSUDATIVE AVEC UN DÈME PERSISTANT
German Title of Invention:
VERWENDUNG VON SIROLIMUS ZUR BEHANDLUNG VON EXSUDATIVER ALTERSBEDINGTER MAKULADEGENERATION MIT PERSISTENTEM ÖDEM
SPC Number:

Dates

Filing date:
25/05/2017
Grant date:
04/08/2021
EP Publication Date:
10/04/2019
PCT Publication Date:
30/11/2017
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
04/08/2021
EP B1 Publication Date:
04/08/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
25/05/2022
Expiration date:
25/05/2037
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
28/07/2021
 
 

Name:
Santen Pharmaceutical Co., Ltd.
Address:
9-19, Shimoshinjo 3-chome, Higashiyodogawa-ku Osaka-shi Osaka 533-8651, Japan (JP)

Inventor

Name:
MATURI, Raj K.
Address:
United States (US)

Priority

Priority Number:
201662341543 P
Priority Date:
25/05/2016
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/436; A61P 7/10; A61P 27/02;

Publication

European Patent Bulletin

Issue number:
202131
Publication date:
04/08/2021
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages